Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Martine Rothblatt is Featured in Forbes Magazine's Special Centennial Issue as one of The World's 100 Greatest Living Business Minds

United Therapeutics Corporation
Posted on: 19 Sep 17
Martine Rothblatt is Featured in Forbes Magazine's Special Centennial Issue as one of The World's 100 Greatest Living Business Minds

PR Newswire


SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Sept. 19, 2017 /PRNewswire/ -- Martine Rothblatt, Chairman and Chief Executive Officer of United Therapeutics Corporation (NASDAQ: UTHR) is featured in Forbes magazine's special centennial issue, released today, as one of The World's 100 Greatest Living Business Minds. In celebration of its 100th anniversary, Forbes magazine's collector's edition features essays, lessons and ideas for the next 100 years from today's most influential business leaders around the world. 

"I'm very honored to help recognize Forbes magazine's centennial," said Dr. Rothblatt. "From my creation of satellite radio to improve life for millions, to my making a medicine to save my daughter that has produced a company worth billions, I'm in love with the transcendent touch of technology. As United Therapeutics moves forward with manufacturing an unlimited supply of transplantable organs, we feel the makings of a new paradigm of abundance from that magical trifecta of engineering, entrepreneurialism and enthusiasm for creating a better life for all. Our organ manufacturing activities will lead United Therapeutics into the trillion dollar industry that regenerative medicine will become."

In developing the list of 100, Forbes sought people who had either created something with a lasting impact on the world or innovated in a way that transcends their given field. Other honorees featured on Forbes' 100 Greatest Living Business Minds list include: Warren Buffett, Bill Gates, Jeff Bezos, Mark Zuckerberg, Elon Musk, Paul McCartney, Oprah Winfrey, Donald Trump, Bono, Ted Turner, Jack Dorsey, Richard Branson, Sean "Diddy" Combs, Sheryl Sandberg, Rupert Murdoch, Miuccia Prada, Shonda Rhimes, Giorgio Armani, Michael Bloomberg and more.

"Our editorial team spent dozens of meetings over two years creating a list that speaks to a century of entrepreneurial capitalism," said Forbes magazine editor Randall Lane. "These are the doers who have created, disrupted and innovated on a collectively historic scale." Honorees were required to actively participate in the project – all essays are original, wisdom from the list-makers themselves. The special Forbes issue showcases portraits by photographer Martin Schoeller. For the full list, visit:

Forbes magazine published its first issue on September 15, 1917. Over the past century, Forbes has been exploring and recording pivotal moments in business with the goal of inspiring the doers to help change the world for the better. Today, the company is leveraging technology to stay true to its mission of championing the entrepreneur as it continues to evolve from a traditional magazine publisher into a technology-driven media and branding business. 

For more information on Forbes' 100th anniversary, please visit: Follow the conversation with #ForbesAt100.

About United Therapeutics

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of innovative products to address the unmet medical needs of patients with chronic and life-threatening conditions. [uthr-g]

Forward-looking Statements

Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, among others, statements regarding the prospects of our organ transplantation-related technologies. These forward-looking statements are subject to certain risks and uncertainties, such as those described in our periodic and other reports filed with the Securities and Exchange Commission that could cause actual results to differ materially from anticipated results. Such forward-looking statements are qualified by the cautionary statements, cautionary language and risk factors set forth in our periodic reports and documents filed with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995 for forward-looking statements. We are providing this information as of September 19, 2017, and assume no obligation to update or revise the information contained in this press release whether as a result of new information, future events or any other reason.

View original content:

SOURCE United Therapeutics Corporation

PR Newswire

Last updated on: 19/09/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.